BRAIN CHEMISTRY OF HEAVY SMOKERS AND DRINKERS, BENEFITS OF FOLIC ACID, AND OTHER NEW DRUG FINDINGS TO BE PRESENTED AT ANNUAL PHARMACOLOGY MEETING
Leading clinical pharmacologists will present the latest research concerning drug interventions and drug interactions during the April 2-5 meeting of the American Society for Clinical Pharmacology and Therapeutics at the Marriott Wardman Park Hotel in Washington, DC. The results of over 300 research studies will cover these and other topics: o How folic acid has reduced the incidence of a common cancer in children o Differences in the brains of heavy smokers and drinkers that make them more prone to alcohol and drug abuse as well as more vulnerable to toxic reactions and brain damage
(PRWEB) March 27, 2003
Washington, DC -- Leading clinical pharmacologists will present the latest research concerning drug interventions and drug interactions during the April 2-5 meeting of the American Society for Clinical Pharmacology and Therapeutics at the Marriott Wardman Park Hotel in Washington, DC.
The results of over 300 research studies will cover these and other topics:
O How folic acid has reduced the incidence of a common cancer in children
O Differences in the brains of heavy smokers and drinkers that make them more prone to alcohol and drug abuse as well as more vulnerable to toxic reactions and brain damage
O A genetic variation affecting about one in every 300 African Americans that influences the processing of dopamine
O A tiny protein pump located in intestinal cells that is responsible for how much relief individuals get from opioids
O Digoxin and carvedilol as a potentially dangerous drug combination for children with heart problems
O A new approach for early detection of prenatal alcohol exposure
O Why adolescents require higher doses than adults of the popular antidepressant, Bupropion
O A drug therapy that alleviates postpartum depression
O Why some women respond more positively than others to tamoxifen
O Why women who conquer Lupus have more heart problems
O How estrogen protects pre-menopausal women from heart problems
O A method for the genetic prescribing of warfarin that cuts in half the time previously needed to stabilize patients with this drug
O Identifying patients who are at risk for serious drug side effects
Other ASCPT annual meeting highlights:
O Ethics of Drug Research in Vulnerable Populations-An International
Perspective, Wednesday, April 2 o 1:15-3 pm
O Prescribing by Ethnicity, Public Policy Forum, Friday, April 4 o 9-11 am
O Closing Debate: Should FDA Regulation of Direct to Consumer Advertisements be
Strengthened? Saturday, April 5
Presenters will summarize this session in the newsroom at 12:30 p. m. on Friday, April 4.
Major speakers are:
Francis Collins, MD, PhD, Director, National Human Genome Research Institute
David Mankoff, MD, PhD, Associate Professor, Nuclear Medicine, University of
Washington
Malcolm Rowland, PhD, Professor and Dean, School of Pharmacy and Pharmaceutical
Sciences, University of Manchester
Eve Slater, MD, former Assistant Secretary of Health, HHS
*****************************************
Online media registration: http://www. ascpt. org/press/PressRegistrationInstructions. htm (http://www. ascpt. org/press/PressRegistrationInstructions. htm)
Updated program: http://www. ascpt. org/ (http://www. ascpt. org/)
Email kholmay@cpcug. org for:
Summaries of highlighted papers.
FDA Survey that will inform the April 5 debate.
Research presented at the ASCPT annual meeting is embargoed until the time of its presentation. To arrange pre-conference interviews, contact Kathleen Holmay.
Newsroom o McKinley Room o 202-745-2118 o fax 202-745-2122
Hours of operation:
Tuesday, 4/1 Noon-6pm
Wednesday 4/2, and
Thursday 4/3, and
Friday 4/4 8am-5pm
Saturday, April 5 8am-Noon
Newsroom registration is limited to credentialed journalists, those with assignment letters on the letterhead of a media organization, and public information officers from non-profit organizations and governmental agencies.
####
